Novel Class of Natural Products to be Developed as Anti-Cancer Therapeutics
Ascenion mediates licence agreement between GBF and Zentaris
07-Jul-2004 -
Ascenion GmbH has mediated a licence agreement between the
German Research Centre for Biotechnology mbH (GBF) and Zentaris GmbH, German
subsidiary of listed Æterna Zentaris Inc.
The licence grants Zentaris exclusive worldwide rights for the development, manufacture and
marketing of ...
Ascenion
bacteria
biotechnology
+2